Bluebird Bio (NASDAQ:BLUE) stock in focus as company intends to go private in M&A deal with Carlyle Group (CG) & SK Capital. Read more here.

The agreement, which also includes a team of biotech executives, will see Bluebird Bio’s stockholders receive $3.00 per share ...

Birds-of-paradise are even colorful in the dark, with feathers and body parts that glow a brilliant yellow-green under ...

The global citizen science project, which runs through Monday, allows scientists to collect data on wild birds, helping to ...

Third-year trainer Rory Hunter has already achieved his dream of having a Blue Diamond runner with a horse he thought would ...

Connor McDavid scores in overtime to give Canada victory over the U.S. in inaugural 4 Nations Face-Off championship game ...

Explore the ultimate list of superhero movies, from Marvel to DC, filled with action, epic battles, inspiring heroes, and ...

Bloomberg on Wednesday reported that X is in talks to raise money that would value the company at $44 billion. The anonymous ...

A long-defunct motel on Flanders Road, converted into apartments, is a reminder of the once-thriving Black business district in Riverside. David Peter Fitzgerald, whose father built the motel in ...

Loaded with a list of nominees across big-ticket categories, competition came close - particularly with the presence of ...